Tech Company Financing Transactions
GentiBio Funding Round
Novartis Venture Fund, OrbiMed and RA Capital joined a $20 million Seed capital raise for GentiBio. The financing round was recorded on 8/6/2020.
Transaction Overview
Company Name
Announced On
8/6/2020
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Boston, MA 02101
USA
Boston, MA 02101
USA
Phone
Undisclosed
Website
Email Address
Overview
At GentiBio, we understand that a balanced immune system is paramount to health and wellness. Certain diseases can turn the immune system against itself, causing the body to attack its own cells and tissues. Regulatory T cells, or Tregs, play a central role in keeping the immune system in check by applying the brakes to runaway immune responses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adel Nada
Browse more venture capital transactions:
Prev: 8/6/2020: Syntiant venture capital transaction
Next: 8/6/2020: Radish venture capital transaction
Share this article
About Database of VC Transactions
We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs